about
Alpha-2 adrenergic receptor agonists: a review of current clinical applicationsDexmedetomidine: an adjuvant making large inroads into clinical practiceTolerance and withdrawal from prolonged opioid use in critically ill children.Current role of dexmedetomidine in clinical anesthesia and intensive care.Dexmedetomidine in current anaesthesia practice- a review.Characterization of dexmedetomidine dosing and safety in neonates and infants.Meta-analysis of dexmedetomidine on emergence agitation and recovery profiles in children after sevoflurane anesthesia: different administration and different dosageDexmedetomidine decreases the emergence agitation in infant patients undergoing cleft palate repair surgery after general anesthesiaDexmedetomidine for Sedation during Withdrawal of Support.Dexmedetomidine for transport of a spontaneously breathing combative child.Intravenous dexmedetomidine during spinal anaesthesia for caesarean section: A meta-analysis of randomized trialsDiscontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteersProlonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical proceduresPediatric sedation--evolution and revolution.Endocrinopathies in the cardiac ICU.The pharmacologic management of delirium in children and adolescents.Dexmedetomidine: New avenues.High dose dexmedetomidine: effective as a sole agent sedation for children undergoing MRI.Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children.Effects of dexmedetomidine in reducing post-cesarean adverse reactions.Dexmedetomidine for sedation in pediatric patients who received more than 20 sessions of radiation therapy: two cases report.Comparative study between dexmedetomidine and fentanyl for sedation during mechanical ventilation in post-operative paediatric cardiac surgical patientsIntranasal Dexmedetomidine as a Sedative for Pediatric Procedural SedationAn introduction to the various role of dexmedetomidine.Combined Use of Etomidate and Dexmedetomidine Produces an Additive Effect in Inhibiting the Secretion of Human Adrenocortical Hormones.Comparison of Adrenal Suppression between Etomidate and Dexmedetomidine in Children with Congenital Heart Disease.Preventive effects of dexmedetomidine on the liver in a rat model of acid-induced acute lung injury.High-dose dexmedetomidine sedation for pediatric MRI.Comparison of the effects of dexmedetomidine, ketamine, and placebo on emergence agitation after strabismus surgery in children.Comparison of buccal and nasal dexmedetomidine premedication for pediatric patients.Comparison of Two Different Intranasal Doses of Dexmedetomidine in Children for Magnetic Resonance Imaging Sedation.
P2860
Q26825701-5DBA6A17-8600-4637-9190-E2C02D401237Q26998814-5A3A8132-A076-4AE0-9D84-ABAA0FA34D2AQ30428413-A9EFB42C-FC6D-409F-AA69-E923AC78B173Q34236559-D99C10F0-913C-4DAA-94AB-2B67673E45F7Q34618104-63FAE14C-4386-42AE-BD31-582267DA7FBCQ35566352-5DB40445-8054-4679-9EE8-364AD3C8E1DDQ35601446-1EE589B8-7E7E-4CBC-8DC8-C4B75AE4D3CFQ35805625-89A83D76-2167-4013-9539-88E70925873EQ36000694-E22C25A9-6EB2-40DF-A5D1-1D1B7062B9BCQ36192876-E236FCD1-0A9B-485D-AACF-3497830124B8Q36384015-DBD595EC-F380-4DB6-A2FA-38C2EE6EBE59Q37090515-B8079EC2-D87C-4AB1-A4F4-18D3FEAC85D0Q37308478-01BC2F95-FCD8-470F-8A47-030ECE37EBBAQ37372847-E196E204-CC44-492D-B22F-B0717B29589FQ37737563-563D64A5-8D62-496E-B4A5-80C4DC4C5606Q37876484-8BCF0C2E-3476-41EF-8047-52552CDCCBC6Q38117258-4E24B859-1661-4633-83BF-2BCCB1797282Q38217727-3BF8F372-F83F-48A8-8B27-15CCA6126C31Q38259776-894FBDE9-86CC-46DA-ADF6-30E07FEFAD09Q38364179-7DDA7FDE-EFEB-44BA-ACF9-E07105CC4767Q39361432-A080FE59-F710-4DDE-AF29-28C9B3CBEAD0Q39870047-02786B06-F53D-440F-9CDB-5900186C212BQ41672463-522F2C9F-832F-4A1D-A3D1-9B93A0FC3E14Q42038119-12B2584B-619E-4610-A351-2C25A8CF361AQ42082983-FA2D20BB-626B-4D17-95EF-833CA3F7D659Q42317632-357B7AB5-101D-41AA-929D-9B8F03FA740FQ42360062-562BFB14-733F-4827-A8FA-F7619848DE86Q42485134-2A8A3CBC-778E-4BF0-BE0B-99443C3A37BAQ42555198-CD7E79C7-AC05-41F0-9C21-DCD259E84ED6Q42820143-29F94707-A70E-445E-8AFE-4C63C5F7D699Q43844873-2E0C7FA3-9643-4AE1-A756-08CF69B73780Q45157066-5F5F1E6A-B686-40FC-8831-2BA5448FDFCFQ46614296-CA452F8A-449F-4882-A83B-DE40BDD0752AQ47658149-38151CE8-8F69-4829-96D6-55DD4895CAC8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical uses of dexmedetomidine in pediatric patients.
@en
Clinical uses of dexmedetomidine in pediatric patients.
@nl
type
label
Clinical uses of dexmedetomidine in pediatric patients.
@en
Clinical uses of dexmedetomidine in pediatric patients.
@nl
prefLabel
Clinical uses of dexmedetomidine in pediatric patients.
@en
Clinical uses of dexmedetomidine in pediatric patients.
@nl
P1433
P1476
Clinical uses of dexmedetomidine in pediatric patients.
@en
P2093
Hanna Phan
Milap C Nahata
P2860
P356
10.2165/00148581-200810010-00006
P577
2008-01-01T00:00:00Z
P6179
1020222937